What is CureMetrix?
CureMetrix is a global leader in applying artificial intelligence (AI) and deep learning to medical imaging, focusing on the development of advanced Computer-Aided Detection (CAD) systems. The company's core mission is to improve cancer survival rates worldwide by providing radiologists, healthcare systems, and patients with reliable and advanced imaging analysis tools. Their technology is designed to deliver superior diagnostic confidence, positioning them at the forefront of AI-driven medical diagnostics.
How much funding has CureMetrix raised?
CureMetrix has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for CureMetrix?
With its substantial late-stage funding and a recent strategic investment, CureMetrix is well-positioned for accelerated growth and market expansion. The capital infusion is expected to fuel further research and development, enhance product deployment, and strengthen strategic partnerships within the healthcare ecosystem. This backing signifies strong investor confidence in CureMetrix's technology and its potential to revolutionize cancer detection and patient outcomes, paving the way for broader adoption of their AI solutions in clinical settings.
See full CureMetrix company page